High-dose hydroxocobalamin administered after H2S exposure counteracts sulfide-poisoning-induced cardiac depression in sheep

Clinical Toxicology

Volumn 53, Issue 1, 2015, Pages 28-36

  Haouzi, Philippe ^a   Chenuel, Bruno ^b   Sonobe, Takashi ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Antidotes; Cardiac contractility; H2S

Indexed keywords

HYDROGEN SULFIDE; HYDROXOCOBALAMIN; LACTIC ACID; SODIUM CHLORIDE;

ADULT; AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL BLOOD; ARTICLE; BLOOD FLOW; BLOOD GAS ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MEGADOSE; ELECTRIC ACTIVITY; ELEVATED BLOOD PRESSURE; HEART ARREST; HEMODYNAMICS; LACTATE BLOOD LEVEL; NONHUMAN; SHEEP; SURVIVAL; ANIMAL; BLOOD PRESSURE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION;

ANIMALIA; OVIS ARIES;

ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HEART ARREST; HEMODYNAMICS; HYDROGEN SULFIDE; HYDROXOCOBALAMIN; INJECTIONS, INTRAVENOUS; SHEEP;

EID: 84920101597     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2014.990976     Document Type: Article

References (51)

1. Haggard HW. The fate of sulfides in the blood. J Biol Chem 1921;49:519-529
2. Beauchamp RO Jr, Bus JS, Popp JA, Boreiko CJ, Andjelkovich DA. A critical review of the literature on hydrogen sulfide toxicity. Crit Rev Toxicol 1984;13:25-97
3. Guidotti TL. Hydrogen sulfide: advances in understanding human toxicity. Int J Toxicol 2010;29:569-581
4. Haouzi P, Sonobe T, Torsell-Tubbs N, Prokopczyk B, Chenuel B, Klingerman CM. In vivo interactions between cobalt or ferric compounds and the pools of sulphide in the blood during and after H2S poisoning. Toxicol Sci 2014;141:493-504
5. Klingerman CM, Trushin N, Prokopczyk B, Haouzi P. H2S concentrations in the arterial blood during H2S administration in relation to its toxicity and effects on breathing. Am J of Physiol Regul Integr Comp Physiol 2013;305:R630-638
6. Toombs CF, Insko MA, Wintner EA, Deckwerth TL, Usansky H, Jamil K, et al. Detection of exhaled hydrogen sulphide gas in healthy human volunteers during intravenous administration of sodium sulphide. Br J Clin Pharmacol 2010;69:626-636
7. Van De Louw A, Haouzi P. Inhibitory effects of hyperoxia and methemoglobinemia on H(2)S induced ventilatory stimulation in the rat. Respir Physiol Neurobiol 2012;181:326-334
8. Truong DH, Mihajlovic A, Gunness P, Hindmarsh W, OBrien PJ. Prevention of hydrogen sulfide (H2S)-induced mouse lethality and cytotoxicity by hydroxocobalamin (vitamin B(12a)). Toxicology 2007;242:16-22
9. Mihajlovic A. Antidotal mechanisms for hydrogen sulfide toxicity. [PhD Thesis]. Toronto 1999
10. Van De Louw A, Haouzi P. Ferric iron and cobalt (III) compounds to safely decrease H2S in the body?. Antioxid Redox Signal 2012 Jan 10. PubMed PMID: 22233239. Epub 2012/01/12. Eng
11. Brenner M, Benavides S, Mahon SB, Lee J, Yoon D, Mukai D, et al. The vitamin B12 analog cobinamide is an effective hydrogen sulfide antidote in a lethal rabbit model. Clin Toxicol 2014 Apr 9. PubMed PMID: 24716792
12. Astier A, Baud FJ. Complexation of intracellular cyanide by hydroxocobalamin using a human cellular model. Human Exp Toxicol 1996;15:19-25
13. Hall CA, Begley JA Atypical cobalamin binding in the serum of congenital deficiency of transcobalamin II. Br J Haematol 1982;51:65-71
14. Hall CA, Begley JA, Green-Colligan PD. The availability of therapeutic hydroxocobalamin to cells. Blood 1984;63:335-341
15. Gimpert E, Jakob M, Hitzig WH. Vitamin B12 transport in blood. I. Congenital deficiency of transcobalamin II. Blood 1975;45:71-82
16. Sharma VS, Pilz RB, Boss GR, Magde D. Reactions of nitric oxide with vitamin B12 and its precursor, cobinamide. Biochemistry 2003;42:8900-8908
17. Rochelle LG, Morana SJ, Kruszyna H, Russell MA, Wilcox DE, Smith RP. Interactions between hydroxocobalamin and nitric oxide (NO): evidence for a redox reaction between NO and reduced cobalamin and reversible NO binding to oxidized cobalamin. J Pharmacol Exp Ther 1995;275:48-52
18. Brouwer M, Chamulitrat W, Ferruzzi G, Sauls DL, Weinberg JB. Nitric oxide interactions with cobalamins: biochemical and functional consequences. Blood 1996;88:1857-1864
19. Gerth K, Ehring T, Braendle M, Schelling P. Nitric oxide scavenging by hydroxocobalamin may account for its hemodynamic profile. Clin Toxicol 2006;44:29-36
20. Altaany Z, Yang G, Wang R. Crosstalk between hydrogen sulfide and nitric oxide in endothelial cells. J Cell Mol Med 2013;17:879-888
21. Coletta C, Papapetropoulos A, Erdelyi K, Olah G, Modis K, Panopoulos P, et al. Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc Natl Acad Sci USA 2012;109:9161-9166
22. Forsyth JC, Mueller PD, Becker CE, Osterloh J, Benowitz NL, Rumack BH, et al. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol 1993;31:277-294
23. Shepherd G, Velez LI. Role of hydroxocobalamin in acute cyanide poisoning. Ann Pharmacother 2008;42:661-669
24. Haouzi P, Chenuel B, Sonobe T, Klingerman CM. Are H2S-trapping compounds pertinent to the treatment of sulfide poisoning?. Clin Toxicol 2014;52:566
25. Almgren T, Dyrssen D, Elgquist B, Johannsson O. Dissociation of hydrogen sulfide in seawater and comparison of pH scales. Mar Chem 1976;4:289-297
26. Millero FJ. The thermodynamics and kinetics of hydrogen sulfide system in natural waters. Mar Chem 1986;18:121-147
27. Van De Louw A, Haouzi P. Ferric Iron and Cobalt (III) compounds to safely decrease hydrogen sulfide in the body?. Antioxid Redox Signal 2013;19:510-516
28. Arnold IM, Dufresne RM, Alleyne BC, Stuart PJ. Health implication of occupational exposures to hydrogen sulfide. J Occup Med 1985;27:373-376
29. EPA. Toxicological Review of Hydrogen Sulfide (CAC No 7783- 06-04). Washington DC: United States Environmental Protection Agency; 2003
30. Reiffenstein RJ, Hulbert WC, Roth SH. Toxicology of hydrogen sulfide. Annu Rev Pharmacol Toxicol 1992;32:109-134
31. Guidotti TL. Hydrogen sulphide. Occup Med (Lond) 1996;46:367-371
32. Fuller DC, Suruda AJ. Occupationally related hydrogen sulfide deaths in the united states from 1984 to 1994. J Occup Environ Med 2000;42:939-942
33. Hagihara A, Abe T, Omagari M, Motoi M, Nabeshima Y. The impact of newspaper reporting of hydrogen sulfide suicide on imitative suicide attempts in Japan. Soc Psychiatry Psychiatr Epidemiol 2013 Jul 14. PubMed PMID: 23851704
34. Reedy SJ, Schwartz MD, Morgan BW. Suicide fads: frequency and characteristics of hydrogen sulfide suicides in the united states. West J Emerg Med 2011;12:300-304
35. Truscott A. Suicide fad threatens neighbours, rescuers. CMAJ 2008;179:312-313
36. DHS. Appendix to Chemical Facility Anti-Terrorism Standards; Final rule (FR No 07-5585). Department of Homeland Security; 2007
37. Tvedt B, Skyberg K, Aaserud O, Hobbesland A, Mathiesen T. Brain damage caused by hydrogen sulfide: a follow-up study of six patients. Am J Ind Med 1991;20:91-101
38. Dorman DC, Moulin FJ, McManus BE, Mahle KC, James RA , Struve MF. Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentrations in the rat brain, liver, lung, and nasal epithelium. Toxicol Sci 2002;65:18-25
39. Cooper CE, Brown GC. The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance. J Bioenerg Biomembr 2008;40:533-539
40. Baldelli RJ, Green FH, Auer RN. Sulfide toxicity: mechanical ventilation and hypotension determine survival rate and brain necrosis. J Appl Physiol (1985) 1993;75:1348-1353
41. Zhang R, Sun Y, Tsai H, Tang C, Jin H, Du J. Hydrogen sulfide inhibits L-type calcium currents depending upon the protein sulfhydryl state in rat cardiomyocytes. PloS One 2012;7: e37073
42. Sun YG, Cao YX, Wang WW, Ma SF, Yao T, Zhu YC. Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes. Cardiovasc Res 2008;79:632-641
43. Zima AV, Blatter LA. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 2006;71:310-321
44. Kerns W II. Management of beta-adrenergic blocker and calcium channel antagonist toxicity. Emerg Med Clin North Am 2007;25:309-331
45. Bouillaud F, Blachier F. Mitochondria and sulfide: a very old story of poisoning, feeding, and signaling?. Antioxid Redox Signal 2011;15:379-391
46. Smith RP. Nitrite treatment for hydrogen sulfide poisoning. Ann Intern Med 1981;95:782
47. Brady AJ, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 1992;263:H1963-1966
48. Hare JM, Colucci WS. Role of nitric oxide in the regulation of myocardial function. Prog Cardiovasc Dis 1995;38:155-166
49. Hare JM, Loh E, Creager MA, Colucci WS. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 1995;92:2198-2203
50. Rastaldo R, Pagliaro P, Cappello S, Penna C, Mancardi D, Westerhof N, et al. Nitric oxide and cardiac function. Life Sci 2007;81:779-793
51. Haouzi P, Bell HJ. Respiratory effects of changing the volume load imposed on the peripheral venous system. Respir Physiol Neurobiol. 2010;171:175-180